Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2025 / August / Sleep, the Best Medicine?
Latest Cornea Research & Innovations Glaucoma Retina

Sleep, the Best Medicine?

IOVS study highlights sleep as modifiable risk factor in age-related ocular disease

By The Ophthalmologist 8/19/2025 1 min read

Share

A recent large-scale prospective cohort study utilizing UK Biobank data has shed new light on the role of sleep duration and quality in the development of age-related ocular diseases – including cataract, primary open-angle glaucoma (POAG), diabetic retinopathy (DR), and age-related macular degeneration (AMD). With over 380,000 participants followed for a median of 12.6 years, the study provides robust longitudinal evidence suggesting that sleep patterns are significant modifiable risk factors in ocular aging.

Original image sourced from: Adobestock.com

The analysis – conducted by a team at the Eye and ENT Hospital, Fudan University, Shanghai – revealed a clear U-shaped association between sleep duration and the risk of cataract, POAG, and DR, with seven hours per night emerging as the optimal duration people should be sleeping.

Both shorter (<6 hours) and longer (≥9 hours) sleep durations were linked to significantly increased risks. For example, sleeping less than four hours per day was associated with a 19% increased risk of cataract, while sleeping for more than nine hours was associated with elevated risks for both POAG and DR. There was no significant association observed between sleep duration and AMD.

Poor sleep quality was independently associated with increased risks of cataract and POAG. While the association with DR was suggestive, it did not reach statistical significance. Notably, frequent insomnia and daytime dozing emerged as two specific sleep behavior traits that increased the risk of cataract, POAG, and – to a lesser extent – AMD.

The findings emphasize the importance of assessing sleep habits in routine ophthalmic evaluations, especially among patients at risk of age-related ocular diseases. Interventions aimed at improving sleep hygiene and reducing systemic inflammation could help to offer novel strategies for delaying ocular aging and preserving vision.

About the Author(s)

The Ophthalmologist

More Articles by The Ophthalmologist

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: